	Liquidités		Date
Acadia Pharmaceuticals	USD 819.69M	27.33M	2025-12
Adma Biologics	USD 61.38M	28.9M	2025-09
ALKERMES	USD 388.57M	227.88M	2025-12
Alterity Therapeutics Limited	AUD 15.77M	9.56M	2023-06
AstraZeneca	USD 8.14B	1.08B	2025-09
BioCryst Pharmaceuticals	USD 84.08M	3.95M	2025-09
Bristol-Myers Squibb	USD 10.21B	5.52B	2025-12
Cipla	INR 7.96B	39.9M	2025-09
Clal Biotechnology	ILS 5.73M	1.71M	2023-12
Compugen	USD 7.46M	985K	2025-09
CSL	USD 2.16B	633M	2025-06
Eli Lilly	USD 7.27B	2.52B	2025-12
Esperion Therapeutics	USD 92.45M	6.39M	2025-09
GlaxoSmithKline	GBP 3.3B	303M	2025-09
Grifols	EUR 979.78M	334.84M	2024-12
Halozyme Therapeutics	USD 133.82M	285.84M	2025-12
Ionis Pharmaceuticals	USD 2.68B	437M	2025-12
J&J	USD 19.71B	1.48B	2025-12
Merck	USD 18.17B	10.16B	2025-09
Minerva Neurosciences	USD 12.29M	2.96M	2025-09
Neurocrine Biosciences	USD 713M	372.8M	2025-12
Novartis	USD 9.56B	2.9B	2025-09
Novavax	USD 268.02M	14.28M	2025-09
Pfizer	USD 1.34B	295M	2025-09
Roche Holding	CHF 7.55B	579M	2025-06
Sanofi	EUR 7.66B	1.25B	2025-12
Takeda	JPY 654.94B	26.55B	2025-12
Vanda Pharmaceuticals	USD 84.85M	14.83M	2025-12

Minerva Neurosciences Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.